BERGENBIO ASA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1486 NOK | -1.20% |
|
-5.59% | -46.55% |
Chart calendar BerGenBio ASA
b04081d6cc16a470a3159db8d.GIpAoA1Neyfq1z303G7MC3Cl3V6jSq2Nch2Hkt5VvTA.a8IR92EqNF2ovl-ZiDuAMjvPjAbVCefvPi7hwKYehGV_-xrVQ39Nd7vjVg~5ad85259150bb4383f94226f64a9578b
Upcoming events on BerGenBio ASA
Past events on BerGenBio ASA
| 14/02/2024 02:30 pm | Q4 2023 Earnings Call |
| 14/02/2024 11:30 am | Q4 2023 Earnings Release |
| 14/11/2023 02:30 pm | Q3 2023 Earnings Call |
| 14/11/2023 11:50 am | Q3 2023 Earnings Release |
| 04/11/2023 09:30 pm | Society for Immunotherapy of Cancer Meeting - Poster Board Number: 598 |
| 23/10/2023 | European Society for Medical Oncology Congress - Poster Number: 1440P |
| 21/10/2023 07:20 pm | European Society for Medical Oncology Congress |
| 23/08/2023 02:15 pm | Q2 2023 Earnings Call |
| 23/08/2023 10:30 am | Q2 2023 Earnings Release |
| 22/06/2023 10:30 am | Q1 2023 Earnings Release |
| 05/06/2023 | American Society of Clinical Oncology Meeting |
| 02/06/2023 02:30 pm | Arctic Securities and Carnegie Conference |
| 23/05/2023 01:30 am | Annual General Meeting |
| 15/05/2023 01:30 pm | Business Update Call |
| 16/02/2023 02:30 pm | FY 2022 Earnings Call |
| 16/02/2023 11:30 am | FY 2022 Earnings Release |
| 15/11/2022 02:30 pm | Q3 2022 Earnings Call |
| 15/11/2022 11:37 am | Q3 2022 Earnings Release |
| 23/08/2022 01:30 pm | Interim 2022 Earnings Call |
| 23/08/2022 11:06 am | Interim 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
|
Net sales Million NOK | Released Forecast Spread | 2,34 0,00 - | 8,90 8,70 2.3% | 0,60 0,00 - | 0,80 0,00 - | 0,39 0,00 - | 0,35 0,00 - |
|
EBITDA Million NOK | Released Forecast Spread | -194 -200 2.83% | -204 -201 -1.49% | -260 -258 -0.97% | -313 -320 2.06% | -305 -317 3.86% | -192 -221 13.41% |
|
EBIT Million NOK | Released Forecast Spread | -195 -190 -2.25% | -204 -200 -2.2% | -261 -259 -0.96% | -315 -321 2.15% | -306 -314 2.56% | -192 -222 13.51% |
|
Earnings before Tax (EBT) Million NOK | Released Forecast Spread | -192 -198 2.91% | -199 -196 -1.8% | -257 -250 -2.78% | -309 -314 1.35% | -302 -309 2.35% | -190 -221 13.71% |
|
Net income Million NOK | Released Forecast Spread | -192 -198 2.94% | -199 -196 -1.8% | -257 -250 -2.78% | -309 -314 1.35% | -302 -309 2.35% | -190 -221 13.71% |
|
EPS NOK | Released Forecast Spread | -3,60 -3,80 5.26% | -3,43 -3,37 -1.78% | -3,43 -3,42 -0.41% | -3,52 -3,57 1.32% | -3,41 -3,49 2.38% | -0,13 -0,13 2.82% |
| Announcement Date | 12/02/19 | 11/02/20 | 10/02/21 | 16/02/22 | 16/02/23 | 14/02/24 |
Quarterly results
| Fiscal Period | December | 2019 S1 | 2020 S1 | 2021 S1 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million NOK | Released Forecast Spread | 8,68 8,68 0.02% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,80 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,39 0,00 - | 0,00 0,00 - | 0,35 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | ||
|
EBITDA Million NOK | Released Forecast Spread | -71,1 -93,0 23.57% | -67,0 -65,0 -3.1% | -78,2 -68,8 -13.82% | -87,9 -73,8 -19.22% | -62,3 -83,8 25.63% | -76,3 -82,0 6.93% | -72,4 -100 27.58% | -28,0 -57,6 51.42% | -43,4 -33,4 -30.07% | -46,2 | -48,3 | -94,5 | -51,9 | -56,5 | |||||
|
EBIT Million NOK | Released Forecast Spread | -176 -168 -4.85% | -71,4 -94,0 24.02% | -67,3 -70,7 4.81% | -78,6 -70,0 -12.18% | -88,2 -75,0 -17.53% | -167 -155 -7.89% | -62,4 -84,1 25.75% | -76,4 -89,1 14.23% | -72,4 -100 27.81% | -43,5 -33,4 -30.37% | |||||||||
|
Earnings before Tax (EBT) Million NOK | Released Forecast Spread | -97,1 -97,7 0.62% | -116 -102 -13.23% | -170 -164 -3.78% | -70,5 -92,3 23.58% | -68,8 -69,2 0.56% | -81,1 -68,9 -17.64% | -84,1 -73,9 -13.73% | -165 -156 -5.79% | -59,8 -82,8 27.8% | -77,2 -81,7 5.48% | -72,0 -99,8 27.88% | -27,9 -58,3 52.09% | -41,6 -33,5 -24.28% | -45,1 | -47,3 | -92,3 | -51,6 | -57,6 | |
|
Net income Million NOK | Released Forecast Spread | -97,1 -97,7 0.62% | -116 -102 -13.23% | -170 -164 -3.78% | -70,5 -92,3 23.58% | -68,8 -69,2 0.56% | -81,1 -68,9 -17.64% | -84,1 -73,9 -13.74% | -165 -156 -5.79% | -59,8 -82,8 27.8% | -77,2 -81,7 5.48% | -72,0 -99,8 27.88% | -48,8 | -27,9 -58,3 52.09% | -41,6 -33,5 -24.28% | -45,1 | -47,3 | -92,3 | -51,6 | -57,6 |
|
EPS NOK | Released Forecast Spread | -1,76 -1,70 -3.53% | -1,59 -1,33 -19.55% | -1,94 -1,86 -4.3% | -0,80 -1,03 22.33% | -0,78 -0,81 3.7% | -0,92 -0,78 -17.95% | -0,95 -0,83 -14.46% | -1,86 -1,75 -6.29% | -0,87 -0,85 -2.35% | -0,15 | -0,01 -0,02 50% | -0,02 -0,01 -100% | -0,02 | -0,02 | -0,03 | -0,02 | -0,02 | ||
| Announcement Date | 19/08/19 | 17/08/20 | 17/08/21 | 16/11/21 | 16/02/22 | 24/05/22 | 23/08/22 | 23/08/22 | 15/11/22 | 16/02/23 | 22/06/23 | 23/08/23 | 14/11/23 | 14/02/24 | - | - | - | - | - |
| Today 01:35 am | EXELIXIS, INC.: Q1 2024 Earnings Release |
| 01/05/2024 | SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release |
| 01/05/2024 | MACROGENICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | REGENXBIO INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | DECIPHERA PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 04:30 pm | NEUROCRINE BIOSCIENCES, INC.: Q1 2024 Earnings Release |
| 02/05/2024 01:35 am | SAREPTA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 | ZENTALIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 02/05/2024 | DENALI THERAPEUTICS INC.: Q1 2024 Earnings Release (Projected) |
| 02/05/2024 | GERON CORPORATION: Q1 2024 Earnings Release |
Past sector events for BerGenBio ASA
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BGBIO Stock
- Calendar BerGenBio ASA
